Amani Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-01.
Amani Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 1, 2026. The filing reports $35M sold. Its industry group is Other Health Care. It names Alice Lee (Executive Officer), Robert Swoboda (Executive Officer), Lauren Cuje (Director) (SEC Form D, October 1, 2026).
Sell to companies like Amani Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Amani Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Amani Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in New York, filed in October 2026, largest first.
Get an email when Amani Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Amani Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Amani Therapeutics, Inc. →Get the full cited report on Amani Therapeutics, Inc.
What the filing shows about Amani Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Amani Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Amani Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Amani Therapeutics, Inc. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $35M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Alice Lee is named as Executive Officer on the Form D that Amani Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 5 people that filing names.
Robert Swoboda is named as Executive Officer on the Form D that Amani Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 5 people that filing names.
Lauren Cuje is named as Director on the Form D that Amani Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 5 people that filing names.
Peter Fong is named as Director on the Form D that Amani Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 5 people that filing names.
Connor Williams is named as Director on the Form D that Amani Therapeutics, Inc. filed with the SEC on 1 October 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-10-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
| Entity | Stated role | Relationship on the filing | Where |
|---|---|---|---|
| -- RTW Holdings VI, LLC | — | Promoter | New York, NEW YORK |
What the filing shows about Amani Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Amani Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Amani Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
These are companies, not individuals — the filing gives them no forename, or names them as a firm. They are listed apart so a firm is never read as a person.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Amani Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Amani Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Amani Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: New York raises, week of 2026-09-28 · Health care raises, week of 2026-09-28 · Health care raises in New York
https://mentionfox.com/funding/amani-therapeutics-inc-form-d-000002